RIP140 and LCoR expression in gastrointestinal cancers

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• RIP140 and LCoR are transcription coregulators forming a complex that influences transcription factor activity and cancer cell proliferation.
• Understanding the role of these coregulators in gastrointestinal cancers is crucial for identifying new therapeutic targets and biomarkers.

Purpose of the Study:

• To investigate the expression patterns of RIP140 and LCoR in human colorectal and gastric cancers.
• To determine the correlation of RIP140 and LCoR expression with clinicopathological features and patient survival.

Main Methods:

• Immunohistochemistry was employed to assess RIP140 and LCoR expression in tumor tissues and adjacent normal tissues.
• Statistical analyses were performed to correlate gene expression with TNM staging, tumor differentiation, and protein markers like E-cadherin and Cyclooxygenase-2.

Main Results:

• RIP140 and LCoR expression levels were highly correlated in both colorectal and gastric cancers.
• Colorectal cancer tissues showed decreased RIP140/LCoR expression compared to normal tissues, while gastric cancer tissues exhibited higher expression.
• Expression correlated with TNM staging, tumor differentiation, E-cadherin, and Cyclooxygenase-2 levels.
• In colorectal cancer, LCoR low/RIP140 high expression was linked to prolonged survival.
• High LCoR expression independently predicted poor prognosis in gastric cancer.

Conclusions:

• RIP140 and LCoR exhibit prognostic relevance in gastrointestinal cancers.
• These coregulators may serve as valuable biomarkers for predicting patient outcomes in colorectal and gastric malignancies.
• Further research into the functional roles of RIP140 and LCoR in these cancers is warranted.